Skip to main content

Table 2 Cohort of oral contraception user and non-user women 15–49 years of age

From: Evidence for treatment with estradiol for women with SARS-CoV-2 infection

Women 15–49 years Oral contraception

Patients in cohort

Odds ratio [95% CI]

Hazard ratio [95% CI]

User

2078

1.0 [0.41–2.4]

0.28 [0.1–1.1]

Non-user

16,814